Compare EKSO & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EKSO | UG |
|---|---|---|
| Founded | 2005 | 1942 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.9M | 30.2M |
| IPO Year | 2012 | 1995 |
| Metric | EKSO | UG |
|---|---|---|
| Price | $11.56 | $6.68 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.50 | N/A |
| AVG Volume (30 Days) | ★ 119.0K | 3.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.63% |
| EPS Growth | ★ 41.76 | N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $12,181,971.00 |
| Revenue This Year | $81.23 | N/A |
| Revenue Next Year | $7.29 | N/A |
| P/E Ratio | ★ N/A | $32.75 |
| Revenue Growth | N/A | ★ 11.91 |
| 52 Week Low | $0.23 | $5.58 |
| 52 Week High | $13.50 | $10.09 |
| Indicator | EKSO | UG |
|---|---|---|
| Relative Strength Index (RSI) | 57.72 | 46.93 |
| Support Level | $9.18 | $6.31 |
| Resistance Level | $12.99 | $6.75 |
| Average True Range (ATR) | 0.96 | 0.15 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 52.07 | 40.00 |
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.